| Jill E Langer, MD | |
|
3400 Spruce Street, Ground Floor Dulles, Philadelphia, PA 19104 | |
| (215) 662-7012 | |
| (215) 349-5627 |
| Full Name | Jill E Langer |
|---|---|
| Gender | Female |
| Speciality | Diagnostic Radiology |
| Experience | 38 Years |
| Location | 3400 Spruce Street, Philadelphia, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003844192 | NPI | - | NPPES |
| 0012319150001 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | MD040110E (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hospital Of Univ Of Pennsylvania | Philadelphia, PA | Hospital |
| Penn Presbyterian Medical Center | Philadelphia, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Penn - Medical Group | 6204730955 | 3031 |
| Clinical Health Care Associates Of New Jersey Pc | 0749180198 | 664 |
News Archive
DURECT Corporation announced today that its licensee, King Pharmaceuticals, has begun a Phase IIb clinical trial to evaluate ELADUR™ (TRANSDUR™-Bupivacaine) for the treatment of chronic low back pain. ELADUR is an investigational transdermal drug patch intended to deliver bupivacaine for up to 3 days from a single application.
To improve access to high-quality, advanced cardiac surgery services in St. Petersburg and south Pinellas County, BayCare Health System has opened a BayCare Cardiovascular and Thoracic Surgery office at St. Anthony's Hospital.
Santarus, Inc., a specialty biopharmaceutical company, today announced the publication of an integrated analysis of two randomized placebo-controlled clinical trials with RHUCIN (recombinant human C1 inhibitor, or rhC1INH), in the October issue of the peer reviewed Journal of Allergy and Clinical Immunology (JACI).
Juggling jobs, kids and the demands of a busy, modern life often comes at the expense of family mealtime at home.
MedClean Technologies, Inc. today announced the Company has entered into a preferred stock purchase agreement with Socius Capital Group, LLC, a Delaware limited liability company, doing business as Socius Life Sciences Capital Group, LLC. Pursuant to the Purchase Agreement, MedClean will receive up to $7.5 million in capital.
› Verified 8 days ago
| Entity Name | Clinical Care Associates Of The University Of Pennsylvania Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972682995 PECOS PAC ID: 4688588866 Enrollment ID: O20031113000301 |
News Archive
DURECT Corporation announced today that its licensee, King Pharmaceuticals, has begun a Phase IIb clinical trial to evaluate ELADUR™ (TRANSDUR™-Bupivacaine) for the treatment of chronic low back pain. ELADUR is an investigational transdermal drug patch intended to deliver bupivacaine for up to 3 days from a single application.
To improve access to high-quality, advanced cardiac surgery services in St. Petersburg and south Pinellas County, BayCare Health System has opened a BayCare Cardiovascular and Thoracic Surgery office at St. Anthony's Hospital.
Santarus, Inc., a specialty biopharmaceutical company, today announced the publication of an integrated analysis of two randomized placebo-controlled clinical trials with RHUCIN (recombinant human C1 inhibitor, or rhC1INH), in the October issue of the peer reviewed Journal of Allergy and Clinical Immunology (JACI).
Juggling jobs, kids and the demands of a busy, modern life often comes at the expense of family mealtime at home.
MedClean Technologies, Inc. today announced the Company has entered into a preferred stock purchase agreement with Socius Capital Group, LLC, a Delaware limited liability company, doing business as Socius Life Sciences Capital Group, LLC. Pursuant to the Purchase Agreement, MedClean will receive up to $7.5 million in capital.
› Verified 8 days ago
| Entity Name | Radiology Associates Of Children's Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467403261 PECOS PAC ID: 0345154399 Enrollment ID: O20050209000265 |
News Archive
DURECT Corporation announced today that its licensee, King Pharmaceuticals, has begun a Phase IIb clinical trial to evaluate ELADUR™ (TRANSDUR™-Bupivacaine) for the treatment of chronic low back pain. ELADUR is an investigational transdermal drug patch intended to deliver bupivacaine for up to 3 days from a single application.
To improve access to high-quality, advanced cardiac surgery services in St. Petersburg and south Pinellas County, BayCare Health System has opened a BayCare Cardiovascular and Thoracic Surgery office at St. Anthony's Hospital.
Santarus, Inc., a specialty biopharmaceutical company, today announced the publication of an integrated analysis of two randomized placebo-controlled clinical trials with RHUCIN (recombinant human C1 inhibitor, or rhC1INH), in the October issue of the peer reviewed Journal of Allergy and Clinical Immunology (JACI).
Juggling jobs, kids and the demands of a busy, modern life often comes at the expense of family mealtime at home.
MedClean Technologies, Inc. today announced the Company has entered into a preferred stock purchase agreement with Socius Capital Group, LLC, a Delaware limited liability company, doing business as Socius Life Sciences Capital Group, LLC. Pursuant to the Purchase Agreement, MedClean will receive up to $7.5 million in capital.
› Verified 8 days ago
| Entity Name | University Of Penn - Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235527342 PECOS PAC ID: 6204730955 Enrollment ID: O20141111000091 |
News Archive
DURECT Corporation announced today that its licensee, King Pharmaceuticals, has begun a Phase IIb clinical trial to evaluate ELADUR™ (TRANSDUR™-Bupivacaine) for the treatment of chronic low back pain. ELADUR is an investigational transdermal drug patch intended to deliver bupivacaine for up to 3 days from a single application.
To improve access to high-quality, advanced cardiac surgery services in St. Petersburg and south Pinellas County, BayCare Health System has opened a BayCare Cardiovascular and Thoracic Surgery office at St. Anthony's Hospital.
Santarus, Inc., a specialty biopharmaceutical company, today announced the publication of an integrated analysis of two randomized placebo-controlled clinical trials with RHUCIN (recombinant human C1 inhibitor, or rhC1INH), in the October issue of the peer reviewed Journal of Allergy and Clinical Immunology (JACI).
Juggling jobs, kids and the demands of a busy, modern life often comes at the expense of family mealtime at home.
MedClean Technologies, Inc. today announced the Company has entered into a preferred stock purchase agreement with Socius Capital Group, LLC, a Delaware limited liability company, doing business as Socius Life Sciences Capital Group, LLC. Pursuant to the Purchase Agreement, MedClean will receive up to $7.5 million in capital.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jill E Langer, MD 3400 Spruce Street, Ground Floor Dulles, Philadelphia, PA 19104 Ph: (215) 662-7012 | Jill E Langer, MD 3400 Spruce Street, Ground Floor Dulles, Philadelphia, PA 19104 Ph: (215) 662-7012 |
News Archive
DURECT Corporation announced today that its licensee, King Pharmaceuticals, has begun a Phase IIb clinical trial to evaluate ELADUR™ (TRANSDUR™-Bupivacaine) for the treatment of chronic low back pain. ELADUR is an investigational transdermal drug patch intended to deliver bupivacaine for up to 3 days from a single application.
To improve access to high-quality, advanced cardiac surgery services in St. Petersburg and south Pinellas County, BayCare Health System has opened a BayCare Cardiovascular and Thoracic Surgery office at St. Anthony's Hospital.
Santarus, Inc., a specialty biopharmaceutical company, today announced the publication of an integrated analysis of two randomized placebo-controlled clinical trials with RHUCIN (recombinant human C1 inhibitor, or rhC1INH), in the October issue of the peer reviewed Journal of Allergy and Clinical Immunology (JACI).
Juggling jobs, kids and the demands of a busy, modern life often comes at the expense of family mealtime at home.
MedClean Technologies, Inc. today announced the Company has entered into a preferred stock purchase agreement with Socius Capital Group, LLC, a Delaware limited liability company, doing business as Socius Life Sciences Capital Group, LLC. Pursuant to the Purchase Agreement, MedClean will receive up to $7.5 million in capital.
› Verified 8 days ago
Joel M Stein, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 3400 Spruce St, Philadelphia, PA 19104 Phone: 215-662-3005 | |
Dr. Sarah Denise Fenerty, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3401 N Broad St, Philadelphia, PA 19140 Phone: 215-707-7237 Fax: 215-707-9389 | |
Joanie M Garratt, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 3400 Spruce St, Philadelphia, PA 19104 Phone: 215-662-3000 Fax: 215-662-7011 | |
Xin Qi Wei, DO Radiology Medicare: Medicare Enrolled Practice Location: 160 E Erie Ave, Philadelphia, PA 19134 Phone: 215-427-5234 | |
Ryan Mcclintock, MD Radiology Medicare: Medicare Enrolled Practice Location: 3400 Spruce Street, Philadelphia, PA 19104 Phone: 215-662-3000 Fax: 215-662-7011 | |
Dr. David P. Friedman, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 111 S 11th St, Suite 3390, Philadelphia, PA 19107 Phone: 215-955-2900 Fax: 215-923-1562 | |
Michel Bilello, MD, PHD Radiology Medicare: Accepting Medicare Assignments Practice Location: 3400 Spruce St, 1 Silverstein, Philadelphia, PA 19104 Phone: 215-662-3005 |